Digest Network How does it work
Network
/
Society
Me
Not verified

Merck & Co., Inc.

What we write about

BiotechnologyHealthIndustriaMedicine - variousPharmaceuticals

173 Press releases

View all press releases
19/12/2025
Labour market
Industria
Politica Interna
Medicine - various
Biotechnology
Sanità
Health
Pharmaceuticals
Oncology
Merck Reaches Agreement With U.S. Government to Expand Access to Medicines and Lower Costs for Americans
Source
Merck & Co., Inc.
Issuer
Business Wire
1.00
0
17/12/2025
Market analysis
Industria
Scienza
Medicine - various
Biotechnology
Health
Pharmaceuticals
Sanità
Oncology
KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) Significantly Improved Event-Free Survival, Overall Survival and Pathologic Complete Response Rates for Cisplatin-Eligible Patients with MIBC When Given Before and After Surgery
Source
Merck & Co., Inc.
Issuer
Business Wire
1.00
0
12/12/2025
Industria
Health
Sanità
Medicine - various
Scienza
Pharmaceuticals
Biotechnology
Merck Receives Positive EU CHMP Opinion for Expanded Use of WINREVAIR™ (sotatercept) in Adults with Pulmonary Arterial Hypertension (PAH, WHO* Group 1 Pulmonary Hypertension)
Source
Merck & Co., Inc.
Issuer
Business Wire
1.00
0
04/12/2025
Industria
Veterinary
Scienza
Food hygiene
Medicine - various
Biotechnology
Health
Pharmaceuticals
Sanità
FDA Conditionally Approves Merck Animal Health's EXZOLT™ CATTLE-CA1 for the Prevention and Treatment of New World Screwworm (Cochliomyia hominivorax) Larvae (myiasis)
Source
Merck & Co., Inc.
Issuer
Business Wire
1.00
0
26/11/2025
Biotechnology
Pharmaceuticals
Health
Eventi
WEB AND SOCIAL NETWORK
Merck to Participate in the Citi 2025 Global Healthcare Conference
Source
Merck & Co., Inc.
Issuer
Business Wire
1.00
0
24/11/2025
Eventi
Industria
Scienza
Food hygiene
Medicine - various
Biotechnology
Health
Pharmaceuticals
Sanità
Oncology
Merck Data to be Presented at ASH 2025 Annual Meeting Showcase Continued Advancements in Hematology Pipeline and Novel Therapeutic Approaches
Source
Merck & Co., Inc.
Issuer
Business Wire
1.00
0
21/11/2025
Industria
Biotechnology
Pharmaceuticals
Medicine - various
Oncology
Sanità
Health
Food hygiene
FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each with Padcev® (enfortumab vedotin-ejfv), as Perioperative Treatment for Adults with Cisplatin-Ineligible Muscle-Invasive Bladder Cancer
Source
Merck & Co., Inc.
Issuer
Business Wire
1.00
0
19/11/2025
Industria
Scienza
HIV, AIDS and autoimmune disorders
Food hygiene
Medicine - various
Biotechnology
Health
Pharmaceuticals
Merck Announces Positive Topline Results from the Pivotal Phase 3 Trial Evaluating Investigational, Once-Daily, Oral, Two-Drug, Single-Tablet Regimen of Doravirine/Islatravir (DOR/ISL) in Treatment-Naïve Adults with HIV-1 Infection
Source
Merck & Co., Inc.
Issuer
Business Wire
1.00
0
19/11/2025
Biotechnology
Health
Pharmaceuticals
Medicine - various
Oncology
Industria
European Commission Approves Subcutaneous Administration of KEYTRUDA® (pembrolizumab) for All Adult Indications Approved in the European Union
Source
Merck & Co., Inc.
Issuer
Business Wire
1.00
0
18/11/2025
Stocks and shares
Health
HIV, AIDS and autoimmune disorders
Sanità
Scienza
Pharmaceuticals
Biotechnology
Merck Announces First-Quarter 2026 Dividend
Source
Merck & Co., Inc.
Issuer
Business Wire
1.00
0

Contact details

Social Media

Followers
0
Compatibility
0